TRILURON® is well tolerated and has a well-established safety profile2

Because the sodium hyaluronate in TRILURON® is the same chemical composition as the sodium hyaluronate in HYALGAN®, the excellent safety and tolerability has been established for TRILURON® through the established excellent safety history of HYALGAN®.3

Safety data2

  • No cases of pseudoseptic arthritis were observed
  • Very low reported rates of adverse events: joint effusion/swelling (4/213, 1.9%), joint pain (2/213, 0.9%), injection site hematoma (2/213, 0.9%) and injection site warmth (1/213, 0.5%)
  • Local adverse events usually were transient and disappeared spontaneously within a few days of resting the affected joint and/or applying ice locally